nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—MMP9—focal segmental glomerulosclerosis	0.712	1	CbGaD
Minocycline—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.0322	1	CbGbCtD
Minocycline—CASP3—nephron—focal segmental glomerulosclerosis	0.0186	0.165	CbGeAlD
Minocycline—IL1B—nephron—focal segmental glomerulosclerosis	0.0149	0.132	CbGeAlD
Minocycline—CASP3—endothelium—focal segmental glomerulosclerosis	0.00878	0.078	CbGeAlD
Minocycline—IL1B—endothelium—focal segmental glomerulosclerosis	0.00702	0.0623	CbGeAlD
Minocycline—SLC22A8—nephron—focal segmental glomerulosclerosis	0.00664	0.0589	CbGeAlD
Minocycline—MMP9—endothelium—focal segmental glomerulosclerosis	0.00585	0.0519	CbGeAlD
Minocycline—CASP1—kidney—focal segmental glomerulosclerosis	0.00429	0.0381	CbGeAlD
Minocycline—CASP1—cortex of kidney—focal segmental glomerulosclerosis	0.00418	0.0371	CbGeAlD
Minocycline—CYCS—kidney—focal segmental glomerulosclerosis	0.00413	0.0367	CbGeAlD
Minocycline—CASP3—nephron tubule—focal segmental glomerulosclerosis	0.00402	0.0357	CbGeAlD
Minocycline—CASP3—kidney—focal segmental glomerulosclerosis	0.00354	0.0314	CbGeAlD
Minocycline—VEGFA—nephron tubule—focal segmental glomerulosclerosis	0.00316	0.0281	CbGeAlD
Minocycline—IL1B—kidney—focal segmental glomerulosclerosis	0.00282	0.0251	CbGeAlD
Minocycline—VEGFA—cortex of kidney—focal segmental glomerulosclerosis	0.00271	0.024	CbGeAlD
Minocycline—SLC22A11—nephron tubule—focal segmental glomerulosclerosis	0.00254	0.0225	CbGeAlD
Minocycline—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00239	0.0212	CbGeAlD
Minocycline—MMP9—kidney—focal segmental glomerulosclerosis	0.00235	0.0209	CbGeAlD
Minocycline—SLC22A11—kidney—focal segmental glomerulosclerosis	0.00223	0.0198	CbGeAlD
Minocycline—SLC22A7—kidney—focal segmental glomerulosclerosis	0.00218	0.0193	CbGeAlD
Minocycline—SLC22A11—cortex of kidney—focal segmental glomerulosclerosis	0.00217	0.0193	CbGeAlD
Minocycline—SLC22A7—cortex of kidney—focal segmental glomerulosclerosis	0.00212	0.0188	CbGeAlD
Minocycline—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00205	0.0182	CbGeAlD
Minocycline—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.00143	0.0127	CbGeAlD
Minocycline—SLC22A8—kidney—focal segmental glomerulosclerosis	0.00126	0.0112	CbGeAlD
Minocycline—Methacycline—ALB—focal segmental glomerulosclerosis	0.00125	0.695	CrCbGaD
Minocycline—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.00123	0.0109	CbGeAlD
Minocycline—Tetracycline—ALB—focal segmental glomerulosclerosis	0.000547	0.305	CrCbGaD
Minocycline—CASP1—Direct p53 effectors—PCNA—focal segmental glomerulosclerosis	0.000509	0.00361	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.000505	0.00358	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000505	0.00358	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.000504	0.00357	CbGpPWpGaD
Minocycline—MMP9—Collagen degradation—MMP2—focal segmental glomerulosclerosis	0.000499	0.00354	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—MMP9—focal segmental glomerulosclerosis	0.000499	0.00354	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—COL4A4—focal segmental glomerulosclerosis	0.000497	0.00352	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000495	0.00351	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000492	0.00349	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.000474	0.00336	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000471	0.00334	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—MMP9—focal segmental glomerulosclerosis	0.00047	0.00334	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—MMP2—focal segmental glomerulosclerosis	0.00047	0.00333	CbGpPWpGaD
Minocycline—CASP3—Syndecan-2-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.000465	0.0033	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—SPP1—focal segmental glomerulosclerosis	0.000465	0.0033	CbGpPWpGaD
Minocycline—VEGFA—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000465	0.0033	CbGpPWpGaD
Minocycline—VEGFA—Beta3 integrin cell surface interactions—FN1—focal segmental glomerulosclerosis	0.000463	0.00328	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000462	0.00328	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000459	0.00326	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—COL4A1—focal segmental glomerulosclerosis	0.000457	0.00324	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—focal segmental glomerulosclerosis	0.000452	0.00321	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.00044	0.00312	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.000438	0.00311	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000438	0.0031	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000431	0.00306	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000428	0.00304	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—GNAQ—focal segmental glomerulosclerosis	0.000419	0.00297	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—SPP1—focal segmental glomerulosclerosis	0.000417	0.00296	CbGpPWpGaD
Minocycline—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—focal segmental glomerulosclerosis	0.000414	0.00294	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000411	0.00291	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—ALB—focal segmental glomerulosclerosis	0.00041	0.00291	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—SPP1—focal segmental glomerulosclerosis	0.000409	0.0029	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000404	0.00287	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—SPP1—focal segmental glomerulosclerosis	0.000404	0.00286	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—PCNA—focal segmental glomerulosclerosis	0.0004	0.00284	CbGpPWpGaD
Minocycline—VEGFA—Beta1 integrin cell surface interactions—SPP1—focal segmental glomerulosclerosis	0.000394	0.00279	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—AGT—focal segmental glomerulosclerosis	0.000391	0.00277	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.000374	0.00265	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.000373	0.00265	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—MMP2—focal segmental glomerulosclerosis	0.000367	0.0026	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000367	0.0026	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000364	0.00258	CbGpPWpGaD
Minocycline—VEGFA—Glypican 1 network—TGFB1—focal segmental glomerulosclerosis	0.000364	0.00258	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000364	0.00258	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00036	0.00256	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—SERPINE1—focal segmental glomerulosclerosis	0.00036	0.00255	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.000357	0.00253	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000356	0.00253	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.00035	0.00248	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000348	0.00247	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000346	0.00246	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.000343	0.00243	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000342	0.00242	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—FN1—focal segmental glomerulosclerosis	0.000341	0.00242	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—FN1—focal segmental glomerulosclerosis	0.00034	0.00241	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000338	0.0024	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.000329	0.00233	CbGpPWpGaD
Minocycline—VEGFA—Beta1 integrin cell surface interactions—FN1—focal segmental glomerulosclerosis	0.000329	0.00233	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000327	0.00232	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000326	0.00231	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000326	0.00231	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000326	0.00231	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000325	0.0023	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.000324	0.0023	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000321	0.00228	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000313	0.00222	CbGpPWpGaD
Minocycline—MMP9—Syndecan-1-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.000309	0.00219	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000306	0.00217	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.000298	0.00211	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00029	0.00206	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000286	0.00203	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—focal segmental glomerulosclerosis	0.000285	0.00203	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—SERPINE1—focal segmental glomerulosclerosis	0.000283	0.00201	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.000282	0.002	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000277	0.00196	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000277	0.00196	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000275	0.00195	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.000275	0.00195	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000275	0.00195	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000274	0.00194	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.000274	0.00194	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000273	0.00194	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00027	0.00192	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.000268	0.0019	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000266	0.00189	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.000253	0.00179	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000252	0.00179	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.000251	0.00178	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000248	0.00176	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000245	0.00174	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—MMP2—focal segmental glomerulosclerosis	0.000242	0.00172	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.00024	0.0017	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000235	0.00167	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.000234	0.00166	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—ALB—focal segmental glomerulosclerosis	0.000234	0.00166	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000231	0.00164	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000231	0.00164	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000225	0.00159	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.000223	0.00158	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	0.000223	0.00158	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—TGFB1—focal segmental glomerulosclerosis	0.000223	0.00158	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	0.00022	0.00156	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000218	0.00155	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000216	0.00153	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—MMP9—focal segmental glomerulosclerosis	0.000215	0.00152	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000213	0.00151	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000213	0.00151	CbGpPWpGaD
Minocycline—CASP1—Immune System—MYH9—focal segmental glomerulosclerosis	0.000212	0.0015	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00021	0.00149	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP2—focal segmental glomerulosclerosis	0.00021	0.00149	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000207	0.00147	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—TGFB1—focal segmental glomerulosclerosis	0.000204	0.00145	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000202	0.00144	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000198	0.0014	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000197	0.0014	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000196	0.00139	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TGFB1—focal segmental glomerulosclerosis	0.00019	0.00135	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000185	0.00131	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000181	0.00128	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.00018	0.00128	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.00018	0.00128	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00018	0.00127	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TGFB1—focal segmental glomerulosclerosis	0.000179	0.00127	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000179	0.00127	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—TGFB1—focal segmental glomerulosclerosis	0.000177	0.00126	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000171	0.00122	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	0.000169	0.0012	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000165	0.00117	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000163	0.00116	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—focal segmental glomerulosclerosis	0.000158	0.00112	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000154	0.00109	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000153	0.00108	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000152	0.00108	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.00015	0.00106	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.00015	0.00106	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000149	0.00106	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	0.000148	0.00105	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—FN1—focal segmental glomerulosclerosis	0.000141	0.001	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	0.000141	0.001	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000136	0.000962	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000136	0.000962	CbGpPWpGaD
Minocycline—IL1B—Immune System—MYH9—focal segmental glomerulosclerosis	0.000132	0.000939	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000132	0.000937	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00013	0.000919	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD79A—focal segmental glomerulosclerosis	0.000128	0.00091	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000128	0.000906	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000125	0.000887	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000125	0.000886	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000125	0.000886	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000123	0.000871	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000122	0.000868	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00012	0.000849	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000117	0.000832	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	0.000115	0.000813	CbGpPWpGaD
Minocycline—CYCS—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000111	0.00079	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000109	0.00077	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000108	0.000768	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000106	0.000751	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000105	0.000742	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000104	0.000738	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.000104	0.000737	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000104	0.000736	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	9.91e-05	0.000703	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CTGF—focal segmental glomerulosclerosis	9.8e-05	0.000695	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	9.72e-05	0.00069	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—LPL—focal segmental glomerulosclerosis	9.57e-05	0.000679	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.52e-05	0.000676	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	9.45e-05	0.00067	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.4e-05	0.000667	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.12e-05	0.000647	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.03e-05	0.000641	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—focal segmental glomerulosclerosis	8.99e-05	0.000638	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	8.86e-05	0.000629	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	8.82e-05	0.000626	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—LPL—focal segmental glomerulosclerosis	8.31e-05	0.000589	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.14e-05	0.000578	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	8.04e-05	0.000571	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—focal segmental glomerulosclerosis	8.02e-05	0.000569	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—focal segmental glomerulosclerosis	7.8e-05	0.000554	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	7.69e-05	0.000546	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.62e-05	0.00054	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	7.41e-05	0.000526	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	7.38e-05	0.000523	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.29e-05	0.000517	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.25e-05	0.000514	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	7.07e-05	0.000502	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.88e-05	0.000488	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LIPC—focal segmental glomerulosclerosis	6.86e-05	0.000487	CbGpPWpGaD
Minocycline—CYCS—Metabolism—LPL—focal segmental glomerulosclerosis	6.79e-05	0.000482	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.56e-05	0.000466	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	6.56e-05	0.000465	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40LG—focal segmental glomerulosclerosis	6.54e-05	0.000464	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—FN1—focal segmental glomerulosclerosis	6.44e-05	0.000457	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—focal segmental glomerulosclerosis	6.41e-05	0.000455	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—focal segmental glomerulosclerosis	6.36e-05	0.000452	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	6.19e-05	0.000439	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.17e-05	0.000438	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.09e-05	0.000432	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CTGF—focal segmental glomerulosclerosis	6.04e-05	0.000428	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.97e-05	0.000424	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—focal segmental glomerulosclerosis	5.86e-05	0.000416	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AGT—focal segmental glomerulosclerosis	5.81e-05	0.000412	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.57e-05	0.000395	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—focal segmental glomerulosclerosis	5.57e-05	0.000395	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.56e-05	0.000395	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	5.36e-05	0.00038	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—focal segmental glomerulosclerosis	5.35e-05	0.00038	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.06e-05	0.000359	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.03e-05	0.000357	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.94e-05	0.00035	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.72e-05	0.000335	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.58e-05	0.000325	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.48e-05	0.000318	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—focal segmental glomerulosclerosis	4.46e-05	0.000316	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.39e-05	0.000312	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.37e-05	0.00031	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.34e-05	0.000308	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.23e-05	0.0003	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LPL—focal segmental glomerulosclerosis	4.19e-05	0.000297	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—focal segmental glomerulosclerosis	4.19e-05	0.000297	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	3.97e-05	0.000282	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.92e-05	0.000278	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.87e-05	0.000274	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.77e-05	0.000267	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.67e-05	0.000261	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.62e-05	0.000257	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AGT—focal segmental glomerulosclerosis	3.58e-05	0.000254	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	3.45e-05	0.000245	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.38e-05	0.00024	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.36e-05	0.000238	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.28e-05	0.000233	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.18e-05	0.000226	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.14e-05	0.000223	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.02e-05	0.000214	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.01e-05	0.000214	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.85e-05	0.000202	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.76e-05	0.000196	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—focal segmental glomerulosclerosis	2.75e-05	0.000195	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.72e-05	0.000193	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.62e-05	0.000186	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.52e-05	0.000178	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.36e-05	0.000168	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.31e-05	0.000164	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.18e-05	0.000155	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.09e-05	0.000148	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.9e-05	0.000135	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.82e-05	0.000129	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.39e-05	9.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.32e-05	9.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.15e-05	8.14e-05	CbGpPWpGaD
